The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancer
Springer Science and Business Media LLC - Trang 1-14 - 2023
Tóm tắt
Studies relying on standardized instruments to measure patient-centered harms and benefits of cancer treatment may fail to capture important elements of the lived experience of cancer patients. Further, qualitative studies on the survivorship experience of men with localized prostate cancer (PCa) are limited. We sought to explore the early experience, long-term experience, and advice provided for others among long-term survivors of localized PCa. Semi-structured qualitative interviews with a subset (n = 66) of respondents to a survey of 10-year PCa survivors who underwent active surveillance, radical prostatectomy, or radiotherapy. Topics included early and long-term experiences and advice to other men and physicians. Immediately after treatment, men were mostly satisfied with radiation and active surveillance due to remaining whole and avoiding surgical removal of the prostate. Meanwhile, men treated with surgery felt relieved by the removal of cancer. Some early negative perception was related to short-term anxiety, particularly among men who underwent active surveillance. Long-term experiences included accepting the trade-offs of urinary and sexual side effects with survival. Most men fared well financially, some had strengthened relationships, and many reported greater appreciation and compassion. Men provided essential advice to other men and physicians on the importance of gathering detailed information on treatments and establishing a strong relationship with physicians. Long-term survivors of localized PCa generally do well by accepting the long-term effects of contemporary treatments, experiencing strengthened relationships, and developing a better overall life approach. We provide useful perspectives and insights for men opting to use current-day treatments for localized PCa.
Tài liệu tham khảo
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.
Schaeffer E, Srinivas S, Antonarakis ES, Armstrong AJ, Bekelman JE, Cheng H, et al. NCCN guidelines insights: prostate cancer, version 1.2021. J Natl Compr Canc Netw. 2021;19(2):134–43. https://doi.org/10.6004/jnccn.2021.0008.
Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–24. https://doi.org/10.1056/NEJMoa1606220.
Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425–37. https://doi.org/10.1056/NEJMoa1606221.
Hoffman KE, Penson DF, Zhao Z, Huang LC, Conwill R, Laviana AA, et al. Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA. 2020;323(2):149–63. https://doi.org/10.1001/jama.2019.20675.
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61. https://doi.org/10.1056/NEJMoa074311.
Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA. 2017;317(11):1126–40. https://doi.org/10.1001/jama.2017.1704.
Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–907. https://doi.org/10.1007/s11135-017-0574-8.
Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753–60. https://doi.org/10.1177/1049732315617444.
Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
Bernard HR, Wutich A, Ryan GW. Analyzing qualitative data: systematic approaches. Second edition. ed. Los Angeles: SAGE; 2017.
Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Los Angeles, CA: Sage Publications; 2012.
Boeije H. A purposeful approach to the constant comparative method in the analysis of qualitative interviews. Qual Quant. 2002;36(4):391–409. https://doi.org/10.1023/A:1020909529486.
Campbell JL, Quincy C, Osserman J, Pedersen OK. Coding in-depth semistructured interviews: problems of unitization and intercoder reliability and agreement. Sociological Methods & Research. 2013;42(3):294–320. https://doi.org/10.1177/0049124113500475.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. https://doi.org/10.1093/intqhc/mzm042.
Marzouk K, Assel M, Ehdaie B, Vickers A. Long-term cancer specific anxiety in men undergoing active surveillance of prostate cancer: findings from a large prospective cohort. J Urol. 2018;200(6):1250–5. https://doi.org/10.1016/j.juro.2018.06.013.
Klotz L. Active surveillance, quality of life, and cancer-related anxiety. Eur Urol. 2013;64(1):37–9. https://doi.org/10.1016/j.eururo.2013.01.023.
Wade J, Donovan J, Lane A, Davis M, Walsh E, Neal D, et al. Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial. BMJ Open. 2020;10(9):e036024. https://doi.org/10.1136/bmjopen-2019-036024.
Kang DW, Fairey AS, Boule NG, Field CJ, Wharton SA, Courneya KS. A randomized trial of the effects of exercise on anxiety, fear of cancer progression and quality of life in prostate cancer patients on active surveillance. J Urol. 2022;207(4):814–22. https://doi.org/10.1097/JU.0000000000002334.
Hoffman RM, Lo M, Clark JA, Albertsen PC, Barry MJ, Goodman M, et al. Treatment decision regret among long-term survivors of localized prostate cancer: results from the prostate cancer outcomes study. J Clin Oncol. 2017;35(20):2306–14. https://doi.org/10.1200/JCO.2016.70.6317.
Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan SH, et al. Association of treatment modality, functional outcomes, and baseline characteristics with treatment-related regret among men with localized prostate cancer. JAMA Oncol. 2022;8(1):50–9. https://doi.org/10.1001/jamaoncol.2021.5160.
Secinti E, Tometich DB, Johns SA, Mosher CE. The relationship between acceptance of cancer and distress: a meta-analytic review. Clin Psychol Rev. 2019;71:27–38. https://doi.org/10.1016/j.cpr.2019.05.001.
Sutton E, Lane JA, Davis M, Walsh EI, Neal DE, Hamdy FC, et al. Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study. Cancer Causes Control. 2021;32(3):261–9. https://doi.org/10.1007/s10552-020-01380-3.
Chambers SK, Chung E, Wittert G, Hyde MK. Erectile dysfunction, masculinity, and psychosocial outcomes: a review of the experiences of men after prostate cancer treatment. Transl Androl Urol. 2017;6(1):60–8. https://doi.org/10.21037/tau.2016.08.12.
Spendelow JS, Eli Joubert H, Lee H, Fairhurst BR. Coping and adjustment in men with prostate cancer: a systematic review of qualitative studies. J Cancer Surviv. 2018;12(2):155–68. https://doi.org/10.1007/s11764-017-0654-8.
Stone BV, Laviana AA, Luckenbaugh AN, Huang LC, Zhao Z, Koyama T, et al. Patient-reported financial toxicity associated with contemporary treatment for localized prostate cancer. J Urol. 2021;205(3):761–8. https://doi.org/10.1097/JU.0000000000001423.
Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology. 2013;22(4):745–55. https://doi.org/10.1002/pon.3055.
Collaco N, Wagland R, Alexis O, Gavin A, Glaser A, Watson EK. The experiences and needs of couples affected by prostate cancer aged 65 and under: a qualitative study. J Cancer Surviv. 2021;15(2):358–66. https://doi.org/10.1007/s11764-020-00936-1.
Mazariego CG, Laidsaar-Powell R, Smith DP, Juraskova I. Avoiding the ‘survivorship abyss’: qualitative insights from 15-year prostate cancer survivors. Psychooncology. 2021;30(10):1745–55. https://doi.org/10.1002/pon.5738.
Vince RA Jr, Jiang R, Bank M, Quarles J, Patel M, Sun Y, et al. Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(1):2250416. https://doi.org/10.1001/jamanetworkopen.2022.50416.